Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems

Ian S Fraser
Contraception · 2012 · vol. 87(3) , pp. 273–279 · doi:10.1016/j.contraception.2012.08.039 · PMID:23040129 · W2079524990
review OA: closed CC0 ⤵ 14 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

MeSH descriptors

Contraceptive Agents, Female Genital Diseases, Female Intrauterine Devices, Medicated Levonorgestrel Contraceptive Agents, Female Female Genital Diseases, Female Humans Levonorgestrel

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (94)

Cited by (14)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:58.344756+00:00
License: CC0 · commercial use OK